Variant position: 1117 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1823 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FFRLEMRNGYLHVFYDFGFS GGPVHLEDTLKKAQINDAKYH
Mouse FFSLEMRNGYLHVFYDFGFS NGPVHLEDTLKKAQINDAKYH
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
25 – 1823 Laminin subunit alpha-4
1047 – 1227 Laminin G-like 2
121 – 1823 Missing. In isoform 3.
Primary structure and expression of a novel human laminin alpha 4 chain.
Iivanainen A.; Sainio K.; Sariola H.; Tryggvason K.;
FEBS Lett. 365:183-188(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); VARIANTS SER-1117 AND ARG-1119;
The complete cDNA sequence of laminin alpha 4 and its relationship to the other human laminin alpha chains.
Richards A.J.; Al-Imara L.; Pope F.M.;
Eur. J. Biochem. 238:813-821(1996)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); VARIANTS HIS-498; SER-1117; ARG-1119 AND SER-1549;
Localization of the gene (LAMA4) to chromosome 6q21 and isolation of a partial cDNA encoding a variant laminin A chain.
Richards A.J.; Al-Imara L.; Carter N.P.; Lloyd J.C.; Leversha M.A.; Pope F.M.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 236-1823 (ISOFORM 2); VARIANTS HIS-498; SER-1117 AND ARG-1119;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.